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Kajian ke atas 50 pesakit Non-Insulin Dependent Diabetes Mellitus (NIDDM) yang  
menjalani pembedahan di bawah anestesia (pelalian) epidural telah dijalankan. Kesemua 
pesakit diberi infusi dekstros 5% 100ml/jam dari masa berpuasa hingga pesakit tiba di bilik 
bedah. Pesakit dibahagikan kepada dua kumpulan secara rawak. Pesakit dalam Kumpulan 
1 (n=25) menerima salin normal manakala pesakit Kumpulan 2 (n=25) diberi laktat Ringer. 
Kedua-dua kumpulan menerima infusi sepanjang masa pembedahan sehingga empat jam 
selepas pembedahan. Aras glukos darah diambil tiga kali, iaitu semasa permulaan 
(baseline), 45 minit semasa pembedahan sedang berjalan, 30 minit dan empat jam 
selepas pembedahan menggunakan glukometer. Hasil kajian menunjukkan paras glukos 
darah min 1.5 mmol/L lebih tinggi pada pesakit Kumpulan 2 di antara empat jam selepas 
pembedahan dan permulaan, (baseline) berbanding dengan 0.96 mmol/L di kalangan 
pesakit Kumpulan 1. Walau bagaimanapun, statistik menunjukkan keputusan ini adalah 
tidak signifikan. Tidak terdapat perbezaan paras glukos min pada 30 minit bila dibezakan 
dengan permulaan (baseline). Paras glukos darah min menunjukkan kenaikan yang 
signifikan pada kedua-dua kumpulan selepas pembedahan apabila dibezakan dengan 
paras glukos di waktu permulaan. Hasil kajian ini menunjukkan bahawa pesakit NIDDM 
yang menerima laktat Ringer mempunyai kenaikan paras glukos darah min yang lebih 
besar apabila dibezakan dengan pesakit yang menerima salin normal, akan tetapi, 
magnitudnya tidak signifikan dari segi statistik. 
 





Fifty Non Insulin Dependent Diabetes Mellitus (NIDDM) patients undergoing surgery under 
epidural anaesthesia were studied. All patients received dextrose 5% infusion at 100 ml/hr 
from the period of fasting until upon arrival to the operation room. Patients were randomly 
divided into two groups. Patients in Group 1 (n=25) received normal saline while patients in 
Group 2 (n=25) were given Ringer’s lactate. Both groups received their infusion throughout 
the operative period up to four hours postoperatively. Blood glucose level was measured at 
baseline, 45 minutes intra operatively and postoperatively at 30 minutes and four hours by 
using a glucometer. Patients in Group 2 has a larger mean increase in blood glucose level 
of 1.5 mmol/L between 4 hours postoperatively and baseline compared to 0.96 mmol/L in 
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Group 1. However, this was not statistically significant. There was no difference in the 
increase of mean glucose level at 30 minutes  when compared to baseline. There was a 
significant increase in mean blood glucose level in both groups in the postoperative period 
when compared to baseline. This study demonstrated that patients with NIDDM receiving 
Ringer’s lactate has a larger increase in mean blood glucose level compared to those 
receiving normal saline, but the magnitude is not statistically significant. 
 







Lactate is a gluconeogenic precursor that 
is rapidly metabolized, particularly during 
starvation or when there is increase in 
body catabolism. A study done by Thomas 
and Alberti showed that in Non Insulin 
Dependant Diabetes Mellitus (NIDDM) 
patients who were given Ringer’s lactate  in 
amount of 29-44 mmol during surgery had 
an increased in mean plasma glucose of 
7.5 mmol/l when compared to those not 
given intravenous fluids amounting only 2.1 
mmol/l (Thomas and Alberti 1978). 
Therefore, higher insulin doses may be 
required for diabetic patients receiving 
Ringer’s lactate during the peri-operative 
period. In another study, it was shown that 
the infusion of Ringer’s lactate at a rate of 
25 µmol/kg/min over three hours in non 
diabetic patients did not alter plasma 
glucose production (Jenssen et al. 1989). 
However, there is no study yet to compare 
the effect of giving normal saline to patients 
with NIDDM when compared to Ringer’s 
lactate. With this interest in mind, a 
prospective randomized study was done to 
evaluate the effect of Ringer’s lactate in 
comparison with normal saline on the 
glycaemic control in patients with NIDDM.  
The aim of this study was to compare the 
intraoperative glycaemic control in patients 
with NIDDM when given either normal 
saline or Ringer’s lactate. 
 
MATERIALS AND METHODS 
 
This was a prospective  randomised 
controlled single blind study carried out in 
Hospital Sultanah Aminah, Johor Bahru. 
After obtaining institutional approval and 
informed consent, 50 ASA II patients with 
NIDDM aged 21-70 years undergoing 
elective or emergency surgical procedures 
under spinal or lumbar epidural 
anaesthesia lasting more than one hour 
were included in the study. Exclusion 
criteria included patients who have 
impaired renal or liver function, allergy to 
the regime solution used and those 
patients where spinal or lumbar epidural 
were contraindicated. 
All patients were assessed pre-
operatively the day before and no 
premedication was served. An infusion of  
dextrose 5% at 100 mls/hr was 
administered once patients fasted until 
their arrival to the operation room. All oral 
hypoglycaemic agents were omitted on the 
day of operation. In the operation theatre, 
patients were randomized into two groups 
using a table of random sampling. Patients 
in Group 1 received normal saline and 
patients in Group 2 received Ringer’s 
lactate. Both regimes were infused at 100 
mls/hr using an infusion pump. Spinal or 
lumbar epidural anaesthesia was then 
performed under aseptic technique using a 
27G Pencan® or 18G Tuohy needle. 
Throughout the operation, all patients were 
monitored with a pulse oximeter, 
electrocardiogram and a non invasive 
blood pressure monitoring device. All 
patients received supplemental oxygen at 6 
l/min via a simple face mask. 
Blood glucose levels were measured 
using a glucometer by the pinprick method. 
Levels were measured at baseline (before 
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performing spinal or epidural blockade), at 
45 minutes intra operatively, at 30 minutes, 
and four hours postoperatively. Other 
parameters recorded include duration of 
anaesthesia, volume of regime fluids 
infused and rescue medication given if any. 
Duration  of  anaesthesia is defined  as 
the time interval from the  onset of neural 
blockade till  completion of  surgery.  
Rescue  action  will  be  taken  if   the  blood 
glucose  level  is below  2.2 mmol/l or more 
than 15.0 mmol/l, according to the British  
National  Formulary 1997; 
 
< 2.2 mmol/l 50 mls dextrose 50% to be given. 
2.2-15.0 mmol/l No action. 
> 15.0 mmol/l 4ü insulin/hr and adjusted 
accordingly. 
 
Hypotension is defined as a drop in 20% 
of systolic blood pressure from baseline and 
is treated with boluses of 5 ml/ kg of the 
infused fluids for the groups respectively. 
Boluses of ephedrine 6mg every 10 minutes 
will be given if hypotension persisted 
despite adequate boluses of fluids given. All 
patients were kept in the recovery room for 
the duration of the study. 
Data was analysed using paired 
Student’s t test and Chi- square test where 
appropriate. A ‘ρ’ value of < 0.05 was used 




Demographic data and patient’s variables 
are shown in Table 1. Both groups were 
comparable in terms of age, weight, sex, 
duration of anaesthesia and volume of 
intravenous fluids given. 
The mean blood glucose levels for the 
two groups is shown in Table 2. There was 
an increase in blood glucose levels with 
time in both groups, except at 45 minutes 
intraoperatively in Group 1. There were 
significant differences in the mean blood 
glucose level between Group 1 and 2 
except at baseline. The increase in the 
mean blood glucose level at 4 hours 
postoperatively when compared to baseline 
is greater in Group 2 which was 1.50 
mmol/L (19%) versus 0.96 mmol/L (13%) in 
Group 1. However, this difference was not 
significant (ρ>0.05). There was no 
difference in the increase of mean blood 
glucose levels in both groups in the 
intraoperative period when compared to 
baseline. Whereas, there was significant 
increase seen in the postoperative period. 
 
 
Table 1:  Demographic data, duration of 
anaesthesia, volume of fluids 
infused and type of cases. Values 
expressed as mean ± standard 
deviation (SD) and number (n) 
where appropriate.     
                   




Age (years) 58.6 ± 8.0 58.1 ± 8.1 
Male: Female 14:11 15:10 
Weight (kg) 62.0 ± 8.7 62.0 ± 10.3 
Mean duration of 
anaesthesia (mins) 
83.4 ± 22.3 81.2 ± 20.2 
Mean IV fluids infused 
( litres ) 
1.26 ± 0.21 1.36 ± 0.35 
Elective: Emergency 
cases 
10 :15 6 : 19 
 
 
Table 2: Mean blood glucose levels at 
different time of anaesthesia for 
two groups. Values expressed as 
mean ± SD, and number (n) 
where appropriate.  
  




Baseline (mmol/l) 7.06 ± 1.97 7.84 ± 2.34 
Intraoperative 
(mmol/l) 45 minutes   
7.05 ± 2.42* 7.89 ± 1.32*
Postoperative  
(mmol/l) 30 minutes   
7.31 ± 2.43* 8.56 ± 0.49*
Postoperative  
(mmol/l)  4 hours 
8.02 ± 2.48* 9.34 ± 0.49*
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DISCUSSION 
                                          
Diabetes mellitus is the commonest 
endocrine disorder encountered in 
anaesthesia and its incidence is increasing 
(Milaskiewicsz and Hall 1992, Scherpereel 
and Tavernier 2001). Ninety percent of 
diabetic patients are NIDDM and this is 
attributed to the sedentary lifestyle, genetic 
predisposition and diet. It is expected that 
the number of people in the world with 
diabetes will double in the next decade 
(Hall et al. 1999). Due to advances in 
medical and surgical therapy, it is likely that 
diabetic individuals have a greater chance 
of undergoing surgery today such as 
vitrectomy, cataract extraction and ulcer 
debridement with good outcome (Hirscjh et 
al. 1991). 
In this study, we are looking specifically 
on the type of solutions in perioperative 
glycaemic control. Hartmann’s solution is 
used interchangeably as Ringer’s lactate in 
daily use. It is often regarded as the 
anaesthetic panacea of fluid resuscitation. 
This crystalloid formulation is routinely 
employed as the rehydration and 
maintenance solution of choice in the 
operation theatre (White and Goldhill 
1997). Often, it is given to diabetic patients 
as an alternative to glucose solutions. 
Lactate is a gluconeogenic precursor, and 
the rate of gluconeogenesis may be 
enhanced in diabetes, particularly in 
situation of stress such as surgery. Infusion 
of lactate may have unwanted metabolic 
effects in diabetic patients.  
There are limited studies on glycaemic 
control in diabetic patients using Ringers 
lactate. In a study by Thomas and Alberti, 
they made a comparison between three 
groups of patients. Group 1 (normal 
patients receiving one litre Ringer’s lactate) 
has a significant increase in blood glucose 
level (55%). Group 2 (NIDDM  patients  not  
receiving  any intravenous fluids)  had only 
22% significant increase in blood glucose 
level. Group 3 (NIDDM patients receiving 
one litre Ringer’s lactate) produce the 
largest significant increase in blood 
glucose level at 88% (Thomas 1978). 
When the percentage increase in plasma 
glucose was compared in diabetic patients 
with or without Ringer’s lactate solution, the 
difference was highly significant. 
Demographically, the above study has a 
similar pattern to this study, except that the 
Thomas and Alberti study has a smaller 
sample (five samples in each group), being 
premedicated and his patients were 
absolutely fasted at least for six hours with 
no dextrose 5% infusion administered. In 
this study, all patients were not 
premedicated and were given normal 
maintenance at 100 mls/hour of dextrose 
5% to prevent the occurrence of 
hypoglycaemia. Patients in Group 2 had an 
increase in mean blood glucose level  of 
1.50 mmol/L (19%) in comparison with 
patients in Group 1 which had only 0.96 
mmol/L (13%) which was not statistically 
significant. However, when compared to 
the Thomas and Alberti study, this study 
shows a marked less increase in mean 
blood glucose level (19% compared to 
88%).  
There are other confounding factors 
which may influence peri-operative 
glycaemic control such as catabolic factor, 
type of solutions and type of surgery. 
Fasting with a maintenance of intravenous 
dextrose 5% solution gives a better 
glycaemic control preoperatively than those 
without it. This has been shown in another 
study by Rauoules, Lugrin and Boussofara 
(1994), in which an infusion of dextrose 5% 
at 125 mls/hr maintains the glycaemic 
control perioperatively. Furthermore, 
normal saline is a non lactated solution, 
therefore, a smaller increase in mean blood 
glucose level is expected when compared 
to Ringer’s lactate.  
In emergency cases, the rate of increase 
in glucose disappearance in response to 
an increase in insulin concentration is 
impaired in people with NIDDM (Turk 
1995). Usually, in emergency cases, 
patients are not well optimised and it is 
assumed the stress response is much 
greater. Thus, most of the time the 
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